ProAir RespiClick Alternatives Compared
| ProAir RespiClick | Dupixent | Advair Diskus |
|
|---|
| ProAir RespiClick (albuterol) | Dupixent (dupilumab) | Advair Diskus (fluticasone / salmeterol) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Asthma - acute, Bronchiectasis, Asthma - Maintenance, Bronchospasm Prophylaxis, COPD - Acute, COPD - Maintenance. ProAir RespiClick may also be used for purposes not listed in this... View more |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Prescription only
Prescribed for Asthma - Maintenance, COPD - Maintenance. Advair Diskus may also be used for purposes not listed in this medication guide. |
Related suggestions Asthma, Maintenance
|
|||||||||||||||||||||||
| More about ProAir RespiClick (albuterol) | More about Dupixent (dupilumab) | More about Advair Diskus (fluticasone / salmeterol) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
ProAir RespiClick has an average rating of 1.5 out of 10 from a total of 108 ratings on Drugs.com. 4% of reviewers reported a positive effect, while 95% reported a negative effect. |
Dupixent has an average rating of 7.1 out of 10 from a total of 467 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 22% reported a negative effect. |
Advair Diskus has an average rating of 7.2 out of 10 from a total of 112 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all ProAir RespiClick prices |
View all Dupixent prices |
View all Advair Diskus prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other albuterol brands include: ProAir HFA, Proventil HFA, Ventolin, Ventolin HFA, Vospire ER |
N/A |
Other fluticasone / salmeterol brands include: Advair HFA, AirDuo Respiclick, Wixela Inhub | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
6.5 hours |
N/A |
12.6 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 421 drugs are known to interact with ProAir RespiClick:
|
A total of 88 drugs are known to interact with Dupixent:
|
A total of 463 drugs are known to interact with Advair Diskus:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
March 28, 2017 |
August 24, 2000 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.